Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.

Kim T, Sall K, Holland EJ, Brazzell RK, Coultas S, Gupta PK

Open source

DOI
10.2147/opth.s185800
Published
2019
Container
Clinical ophthalmology (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s185800,
  title = {Safety and efficacy of twice daily administration of KPI-121 1\% for ocular inflammation and pain following cataract surgery.},
  author = {Kim T and Sall K and Holland EJ and Brazzell RK and Coultas S and Gupta PK},
  year = {2019},
  journal = {Clinical ophthalmology (Auckland, N.Z.)},
  doi = {10.2147/opth.s185800},
  url = {https://doi.org/10.2147/opth.s185800}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.
AU  - Kim T
AU  - Sall K
AU  - Holland EJ
AU  - Brazzell RK
AU  - Coultas S
AU  - Gupta PK
PY  - 2019
JO  - Clinical ophthalmology (Auckland, N.Z.)
DO  - 10.2147/opth.s185800
UR  - https://doi.org/10.2147/opth.s185800
ER  - 

APA

T, K., K, S., EJ, H., RK, B., S, C., & PK, G. (2019). Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s185800

Source records